IGF-1 Clinical Trials

• Recombinant Human Insulin-Like Growth Factor (rhIGF-1)Treatment of Short Stature Associated with IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125190 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency; IGF-1
  
• Prepubertal Children with Growth Failure Associated with Primary IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00125164 - Active, not recruiting
  Insulin-Like Growth Factor-1 Deficiency; Primary IGF-1 Deficiency
  
• The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves’Ophthalmopathy
  ClinicalTrials.gov Identifier: NCT00174057 - Recruiting
  Graves' Ophthalmopathy
  
• Treatment of Children and Adolescents With Growth Failure Associated With Primary Insulin-Like Growth Factor-1 (IGF-1) Deficiency
  ClinicalTrials.gov Identifier: NCT00330668 - Recruiting
  Primary IGF-1 Deficiency; Growth Disorders
  
• Safety Profile of IGF-I Administration in Adolescents
  ClinicalTrials.gov Identifier: NCT00516386 - Recruiting
  Anorexia Nervosa
  
• Study Of Anti-IGF-IR CP-751,871 In Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00474760 - Recruiting
  Sarcoma, Ewing's; Myosarcoma
  
• IGF-1/ALS Trial
  ClinicalTrials.gov Identifier: NCT00035815 - Completed
  Amyotrophic Lateral Sclerosis
  
• A Study to Optimize Growth Hormone Dosing in Children With Chronic Kidney Disease by Measuring Insulin-Like Growth Factor-1 (IGF-1) Levels in Blood
  ClinicalTrials.gov Identifier: NCT00212758 - Active, not recruiting
  Kidney Failure, Chronic; Growth
  
• Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
  ClinicalTrials.gov Identifier: NCT00234533 - Recruiting
  Turner Syndrome; Renal Insufficiency, Chronic; Pituitary Diseases; Dwarfism
  
• Growth Hormone Secretagogue MK-677 Therapy Effect on IGF-1 Levels in CKD and ESRD Patients
  ClinicalTrials.gov Identifier: NCT00395291 - Recruiting
  Chronic Kidney Disease; End Stage Renal Disease
  
• GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00495846 - Recruiting
  Advanced Hepatocellular Carcinoma
  
• IGF-I/IGFBP-3 Therapy in Children and Adolescents With Growth Hormone Insenitivity Syndrome (GHIS) Such as Laron Syndrome
  ClinicalTrials.gov Identifier: NCT00368173 - Active, not recruiting
  Growth Hormone Insensitivity Syndrome (GHIS); Laron Syndrome
  
• IGF-1 Therapy in Patients With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00566241 - Recruiting
  Cystic Fibrosis
  
• rhGH and rhIGF-1 Combination Therapy in Children With Short Stature Associated With IGF-1 Deficiency
  ClinicalTrials.gov Identifier: NCT00572156 - Not yet recruiting
  Insulin-Like Growth Factor-1 Deficiency
  
• Effect of a High Protein Diet on the 24-hour Profile of Ghrelin, GH (Growth Hormone) and IGF-1 (Insulin-like Growth Factor-1)
  ClinicalTrials.gov Identifier: NCT00108225 - Recruiting
  Diabetes Mellitus, Type 2
  
• Epidemiology of Insulin Growth Factor (IGF) and Cardiovascular Events
  ClinicalTrials.gov Identifier: NCT00086424 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Myocardial Infarction; Cerebrovascular Accident; Heart Failure; Heart Failure, Congestive
  
• Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)
  ClinicalTrials.gov Identifier: NCT00497562 - Completed
  Fibromyalgia; Growth Hormone Deficiency
  
• Norditropin in Insulin-like Growth Factor (IGF) Deficient Children
  ClinicalTrials.gov Identifier: NCT00102817 - Completed
  Dwarfism, Pituitary
  
• Canadian Pegvisomant Compassionate Study In Acromegalic Patients
  ClinicalTrials.gov Identifier: NCT00151437 - Completed
  Acromegaly
  
• Comparable Effects of Lanreotide Autogel and Octreotide LAR on GH, IGF-I Levels and Patient Satisfaction
  ClinicalTrials.gov Identifier: NCT00145405 - Completed
  Acromegaly
  
• Effect of Pegvisomant on GH/IGF-I Relationship in GHD
  ClinicalTrials.gov Identifier: NCT00468624 - Terminated
  Severe Adult Growth Hormone Deficiency